Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Making smart drugs that deliver the right kind of punch

24.03.2004


It’s a bitter irony of cancer therapy: treatments powerful enough to kill tumor cells also harm healthy ones, causing side effects that diminish the quality of the lives that are saved.


Nanoparticles depicted here among cells (green) show potential as targeted anti-cancer therapeutics.
Image: Paul Trombley, University of Michigan Center for Biologic Nanotechnology



Researchers at the University of Michigan’s Center for Biologic Nanotechnology hope to prevent that problem by developing "smart" drug delivery devices that will knock out cancer cells with lethal doses, leaving normal cells unharmed, and even reporting back on their success. A graduate student involved in the multidisciplinary project will discuss her recent work---zeroing in on characteristics that make the devices most effective---at a meeting of the American Physical Society in Montreal, Quebec, March 23.

The U-M group is using lab-made molecules called dendrimers, also known as nanoparticles, as the backbones of their delivery system. Dendrimers are tiny spheres whose width is ten thousand times smaller than the thickness of a human hair, explains physics doctoral student Almut Mecke. "These spheres have all sorts of loose ends where you can attach things---for example, a targeting agent that can recognize a cancer cell and distinguish it from a healthy cell. You can also attach the drug that actually kills the cancer cells. If you have both of these functions on the same molecule, then you have a smart drug that knows which cells to attack."


Mecke’s part of the project focuses on finding out how to get dendrimers into cancer cells without disrupting healthy cells. Previous work had shown that high concentrations of dendrimers are toxic---even without their cancer drug cargo---but no one was sure why that was or what could be done about it. Mecke used an atomic force microscope---a device so sensitive it can take pictures of single molecules---to spy on interactions between dendrimers and membranes similar to those that surround living cells.

The atomic force microscope is something like a phonograph with a motion detector attached to its needle. "As the tip moves across the surface, you can detect its movement each time it hits a bump," Mecke said. "If you scan the surface, line by line, and you record the motion of the tip, you get a three-dimensional image of the surface," where each bump is an individual molecule. By taking a series of pictures and putting them together into a movie, Mecke could watch dendrimers in action. What she saw was that "certain kinds of dendrimers disrupt membranes by literally punching holes in them."

That wasn’t the kind of punch the researchers wanted to deliver, so they tried tinkering with the dendrimers to see if they could prevent the damage. "Dendrimers usually have a charge, and so do cell membranes," Mecke said. "It’s the interaction between those charges that causes dendrimers to bind to cell membranes and disrupt them. What our group found is that if you modify the surface of the dendrimers chemically, they become uncharged" and no longer beat up on membranes.

Other research at the center showed that charged dendrimers are just as likely to enter healthy cells as cancer cells---a habit that makes them undesirable for cancer therapy---but that uncharged dendrimers don’t invade cells at all unless they have cancer-detecting targeting agents attached. "We can show that, with the targeting molecule attached, an uncharged dendrimer goes into cancer cells---and only cancer cells---and that’s what we want," Mecke said.

Early results of studies with mice show that the nanoparticle drugs do treat cancer effectively with fewer side effects than conventional chemotherapy drugs, just as the researchers had hoped. "It’s nice to see how everything fits together---my work with the model membrane, my colleague’s work with cell culture and other people’s work with the animal studies," Mecke said. Next, the researchers hope to add more functions to their dendrimer-drug devices, such as biosensors that can report on cancer cell death, indicating how successful a particular treatment has been.

Mecke collaborated on the work with U-M researchers Seungpyo Hong, a graduate student in the macromolecular science and engineering center; Anna Bielinska, a research investigator at the Center for Biologic Nanotechnology; Mark Banaszak Holl, associate professor of chemistry; Bradford Orr, professor of physics; and professor James Baker, director of the Center for Biologic Nanotechnology. Funding was provided by the National Cancer Institute’s Unconventional Innovations Program. The study is one of several major research programs under way in the U-M Center for Biologic Nanotechnology---a multi-disciplinary group that focuses on biologic applications of nanomaterials. Baker, the Ruth Dow Doan Professor of Biologic Nanotechnology in the U-M Medical School, is the study’s principal investigator.

Nancy Ross Flanigan | University of Michigan
Further information:
http://www.umich.edu/news/index.html?Releases/2004/Mar04/r032304

More articles from Health and Medicine:

nachricht Satellites, airport visibility readings shed light on troops' exposure to air pollution
09.12.2016 | Veterans Affairs Research Communications

nachricht Oxygen can wake up dormant bacteria for antibiotic attacks
08.12.2016 | Penn State

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Electron highway inside crystal

Physicists of the University of Würzburg have made an astonishing discovery in a specific type of topological insulators. The effect is due to the structure of the materials used. The researchers have now published their work in the journal Science.

Topological insulators are currently the hot topic in physics according to the newspaper Neue Zürcher Zeitung. Only a few weeks ago, their importance was...

Im Focus: Significantly more productivity in USP lasers

In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.

Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...

Im Focus: Shape matters when light meets atom

Mapping the interaction of a single atom with a single photon may inform design of quantum devices

Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

Researchers identify potentially druggable mutant p53 proteins that promote cancer growth

09.12.2016 | Life Sciences

Scientists produce a new roadmap for guiding development & conservation in the Amazon

09.12.2016 | Ecology, The Environment and Conservation

Satellites, airport visibility readings shed light on troops' exposure to air pollution

09.12.2016 | Health and Medicine

VideoLinks
B2B-VideoLinks
More VideoLinks >>>